ENTERA BIO IS-0000769 (5DT) — Tangible Net Worth Ratio
ENTERA BIO IS-0000769 (5DT) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets (€0.00) from net assets (€7.27 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of ENTERA BIO IS-0000769 to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ENTERA BIO IS-0000769 Tangible Net Worth Ratio (2021–2025)
This chart shows how ENTERA BIO IS-0000769's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of €7.27 Million with intangible assets of €0.00 EUR. For live market cap and overall valuation, see 5DT market cap.
Annual Tangible Net Worth Ratio for ENTERA BIO IS-0000769 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ENTERA BIO IS-0000769 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See ENTERA BIO IS-0000769 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | €13.10 Million | €0.00 | €15.99 Million | ▲ +0.0 pp |
| 2024 | 100.0% | €8.08 Million | €0.00 | €9.39 Million | ▲ +0.0 pp |
| 2023 | 100.0% | €10.39 Million | €0.00 | €11.77 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €11.75 Million | €0.00 | €13.13 Million | ▲ +0.0 pp |
| 2021 | 100.0% | €22.57 Million | €0.00 | €25.99 Million | — |